Frenkel Topping Group plc
("Frenkel Topping" or "the Company")
Director Dealing
Frenkel Topping Group (AIM: FEN), a specialist professional and financial services firm operating in the Personal Injury (PI) Clinical Negligence (CN) space, announces that on 25 August 2023, Mark Holt, Chief Operating Officer as well as senior manager Simon Callow, Chief Investment Officer of Ascencia Investment Management, purchased 130,000 and 185,000 ordinary shares of 0.5p each in the Company ("Ordinary Shares"), respectively, each at a price of 54 pence per Ordinary Share (the "Transactions").
Following the Transactions, Mark Holt's beneficial interest in the Company is 459,791 Ordinary Shares, representing approximately 0.36 per cent. of the total issued share capital.
Further details regarding the Transactions are set out in the disclosure tables below.
For further information:
| Frenkel Topping Group plc | |
| Richard Fraser, Chief Executive Officer | Tel: 0161 886 8000 |
| | |
| finnCap Ltd | Tel: 020 7220 0500 |
| Carl Holmes/Abigail Kelly/Milesh Hindocha (Corporate Finance) Tim Redfern / Charlotte Sutcliffe (ECM) | |
About Frenkel Topping Group
The Frenkel Topping Group of companies specialises in providing financial advice and asset protection services to clients at times of financial vulnerability, with particular expertise in the field of personal injury (PI) and clinical negligence (CN).
For more than 30 years the Group has worked with legal professionals and injured clients themselves to provide pre-settlement, at-settlement and post-settlement services to help achieve the best long-term outcomes for clients after injury. It boasts a client retention rate of 99%.
Frenkel Topping Group is focused on consolidating the fragmented PI and CN space in order to provide the most comprehensive suite of services to clients and deliver a best-in-class service offering from immediately after injury or illness and for the rest of their lives.
The group's services include the Major Trauma Signposting Partnership service inside NHS Major Trauma Centres, expert witness, costs, tax and forensic accountancy, independent financial advice, investment management, and care and case management.
The Group's discretionary fund manager, Ascencia, manages financial portfolios for clients in unique circumstances, often who have received a financial settlement after litigation. In recent years Ascencia has diversified its portfolios to include a Sharia-law-compliant portfolio and a number of ESG portfolios in response to increased interest in socially responsible investing (SRI).
Frenkel Topping has earned a reputation for commercial astuteness underpinned by a strong moral obligation to its clients, employees and wider society, with a continued focus on its Environmental, Social and Governance (ESG) impact.
For more information visit: www.frenkeltoppinggroup.co.uk
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Mark Holt | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Mark Holt, Chief Operating Officer | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Frenkel Topping Group plc | ||||
| b) | LEI | 213800I5L3K7AT7A4R20 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument
| Ordinary Shares of 0.5 pence each | ||||
| Identification code | GB00B01YXQ71 | |||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: ·Aggregated volume ·Price |
Purchase of 130,000 shares @ a price of 54 pence | ||||
| e) | Date of the transaction | 25/08/23 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
